Skip to main content
Caplight Logo









Scandinavian Biolabs

Scandinavian Biolabs

Private
CopenhagenConsumer & Commercehttps://scandinavianbiolabs.com/

Last Round

Series A

Sep 18, 2024

Total Funding Raised

$6.2M

Company Overview

Scandinavian Biolabs is a personal products company that offers science-backed, plant-based hair growth and loss prevention products.

Sector

Consumer & Commerce

Verticals

D2C Brands, Fashion & Beauty, Subscription Commerce, Biotechnology

Business Model

B2C

Customer Profile

Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

hair growth serumhair loss treatmenthair thinningplant-based hair careDTCdirect-to-consumersubscription boxhair growth supplementsnatural hair productsbiotech hair carehair follicle healthclean beautysubscription commercebio-cosmetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scandinavian Biolabs Comparables

Compare Scandinavian Biolabs with similar companies based on industry and business-model similarity.

Scandinavian Biolabs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VEGAMOUR
87%
Hairlust
85%
Divi Scalp & Hair Health
84%

Scandinavian Biolabs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 18, 2024
Pre SeedJun 22, 2021

Key People

Founding team and executive leadership

Niels Konradi

Co-Founder COO

Founding Team

Ariana B.

Chief Marketing Officer

Executive Team

Scandinavian Biolabs Investors

Notable investors and investment history

Scandinavian Biolabs investors
InvestorRounds
Auréa GroupSeries A
Blazar CapitalPre Seed, Series A
SevenVenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 7, 2025

    Added Well Pharmacy Ltd as a customer.

  • Dec 7, 2025

    Added Oloapteekki, a pharmacy company, as a customer.

Scandinavian Biolabs Filings

Explore SEC and related filing metadata, where available.

Scandinavian Biolabs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Scandinavian Biolabs's valuation, stock price, and market status.

Is Scandinavian Biolabs a public or private company?

Scandinavian Biolabs is a private company.

What is the current stock price of Scandinavian Biolabs?

Scandinavian Biolabs is a private company with no public stock price. No recent secondary market data is available.

How much is Scandinavian Biolabs worth (valuation)?

Valuation information for Scandinavian Biolabs is not publicly available.

Can I buy Scandinavian Biolabs stock?

Scandinavian Biolabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Scandinavian Biolabs's last funding round?

Scandinavian Biolabs's most recent funding round was Series A on September 18, 2024.

Who are the main investors in Scandinavian Biolabs?

Key investors in Scandinavian Biolabs include Auréa Group, Blazar Capital.

Will Scandinavian Biolabs IPO soon?

No public IPO plans have been announced for Scandinavian Biolabs.

How can I track Scandinavian Biolabs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scandinavian Biolabs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCopenhagen
Employee Range33
Year Founded2020
Last FundingSep 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?